ABBOTT LABORATORIES Deferred Income Tax 2008-2025 | ABT
Beta
What is deferred income tax?
Deferred income tax represents the difference between income tax expense recognized on the income statement and the actual tax liability paid.
What is ABBOTT LABORATORIES's current deferred income tax?
ABBOTT LABORATORIES (ABT) annual deferred income tax for 2025 was $441.0M, a 105.54% increase from 2024.
What was ABBOTT LABORATORIES's deferred income tax in 2024?
ABBOTT LABORATORIES annual deferred income tax for 2024 was $-7.96B, a 1626.90% decline from 2023.
What was ABBOTT LABORATORIES's deferred income tax in 2023?
ABBOTT LABORATORIES annual deferred income tax for 2023 was $-461.0M, a 30.05% increase from 2022.
Deferred Income Tax History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-108.0M
→
FY2025
$441.0M
080910111213141516171819202122232425
5 years selected
Deferred Income Tax History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $441.0M | +105.5% | 10-K |
| FY2024 | $-7.96B | -1626.9% | 10-K |
| FY2023 | $-461.0M | +30.0% | 10-K |
| FY2022 | $-659.0M | -29.5% | 10-K |
| FY2021 | $-509.0M | -371.3% | 10-K |
| FY2020 | $-108.0M | +78.0% | 10-K |
| FY2019 | $-491.0M | -165.9% | 10-K |
| FY2018 | $745.0M | +183.7% | 10-K |
| FY2017 | $-890.0M | -600.8% | 10-K |
| FY2016 | $-127.0M | -143.3% | 10-K |
| FY2015 | $293.0M | -3.0% | 10-K |
| FY2014 | $302.0M | +169.7% | 10-K |
| FY2013 | $-433.0M | +64.9% | 10-K |
| FY2012 | $-1.23B | -712.9% | 10-K |
| FY2011 | $201.0M | +116.6% | 10-K |
| FY2010 | $-1.21B | -265.1% | 10-K |
| FY2009 | $733.0M | +186.4% | 10-K |
| FY2008 | $-848.0M | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →